Results 71 to 80 of about 104,653 (259)
ABSTRACT We describe a novel variation of hybrid TPVR using a tricuspid annuloplasty ring which can be considered for patients with very large RVOT, short pulmonary artery, and limited vascular access and to avoid the risk of cardiopulmonary bypass. The utilization of Carpentier‐Edwards Physio Tricuspid annuloplasty ring can reduce the size of the RVOT
Mann Chandavimol+4 more
wiley +1 more source
Effects of gender and ethnicity on outcomes after aortic valve replacement [PDF]
ObjectiveTo evaluate the clinical outcomes after aortic valve replacement or aortic valve replacement and coronary artery bypass grafting in a large contemporary population, and to determine if outcomes are associated with patient ethnicity and gender ...
Lovett, Ann+5 more
core +1 more source
ABSTRACT Background Historically, bilateral pulmonary artery band (PAB) placement was guided by pulmonary blood flow surrogates including systemic blood pressure (BP) and arterial saturation. These metrics alone may result in suboptimal bPAB placement.
Jonathan Pacella+8 more
wiley +1 more source
A Giant Dissecting Aneurysm of Ascending Aorta Following Aortic Valve Replacement [PDF]
Ascending aortic dissection and aneurysm are rare but life-threatening complications after aortic valve replacement. Preoperative evaluation of risk factors such as aortic diameter, structural features of aortic wall, and associated diseases may ...
Egemen Duygu+4 more
core +2 more sources
ABSTRACT Patients undergoing transcatheter aortic valve implantation (TAVI) often require long‐term oral anticoagulation (OAC), but it is unclear whether to continue or interrupt OAC during the procedure. This meta‐analysis compares clinical outcomes of continuing versus interrupting OAC during TAVI.
Jefferson Manoel Borges Martins+9 more
wiley +1 more source
Figure-8 Tachycardia Confined to the Anterior Wall of the Left Atrium [PDF]
Incisional atrial tachycardias have been described most frequently in patients with previous corrective surgery for congenital heart defects and mitral valve disease.
Jönsson, Anders+2 more
core +1 more source
Six year clinical study of use of the Omniscience valve prosthesis in 219 patients [PDF]
A 6 year experience of cardiac valve replacement with the Omniscience prosthesis is described. A total of 253 valves were inserted in 219 patients. The survivors were followed up for a total of 536 patient-years and for a mean of 2.8 years. The follow-up
Callaghan, John C.+2 more
core +1 more source
ABSTRACT Transcatheter aortic valve implantation (TAVI) has changed the treatment of aortic stenosis. The Myval transcatheter heart valve (THV), a novel balloon‐expandable THV, has shown promising outcomes. Our aim is to compare the comparative safety and effectiveness of Myval THV against established THVs, such as Sapien and Evolut.
Anastasios Apostolos+8 more
wiley +1 more source
ABSTRACT Valve‐in‐valve (ViV) Transcatheter aortic valve replacement (TAVR) has emerged as a valid treatment option in symptomatic patients with failed aortic bioprosthetic valves, most especially in those with intermediate, high or prohibitive risk of surgery. Due to the unique design of stentless bioprosthetic valves with absence of visible posts and
Adeogo Akinwale Olusan+3 more
wiley +1 more source
ABSTRACT Background Plug‐based vascular closure devices (Pb‐VCD) and suture‐based vascular closure devices (Sb‐VCD) are used for percutaneous vascular access site closure during transcatheter aortic valve replacement (TAVR). Until now, no clear superiority of either device was shown in studies comparing 18 F VCDs solely.
Tobias Lerchner+6 more
wiley +1 more source